Pharmaceuticals News
Subscribe to pharmaceutical news about research, development, manufacturing and marketing of prescription and over the counter drugs. Find the latest on FDA approvals, compliance, competition, management and distribution of pharmaceutical products as well as pharmaceutical business intelligence.
Biogen, Teva, Medimmune, Pfizer, Shire to Share Insights and Project Updates at Pre-Filled Syringes West Coast 2016
SMi Group Reports (2016.03. 08, San Diego, California, USA): Registration is now open to attend Pre-Filled Syringes West Coast 2016 in San Diego. - March 12, 2016 - SAE Media Group
A Tale of Two New Hepatitis C Drugs
Despite discount, Merck’s just approved Zepatier unlikely to win share with most US payers, except in Medicaid, according to RxScorecard™. New combo from Gilead could ensure company’s dominant position among US payers. - March 11, 2016 - Real Endpoints
Earn CPD Points as You Prepare Yourself for New Compliance Guidelines
SMi Training's CPD accredited masterclass: “Compliance with the New Regulations for Medical Devices and In Vitro Diagnostic Products” will take place on the 4th April in London, UK. - March 11, 2016 - SAE Media Group
Reducing Risk with Containment of Highly Potent API’s Addressed Later This Month
SMi Training's CPD accredited masterclass: “Containment of Highly Potent API’s” will take place on the 22nd March 2016 in London, UK. - March 11, 2016 - SAE Media Group
The 2016 SAPA Career Forum Discussions with Young Professionals
On February 27, 2016, Sino-American Pharmaceutical Professionals Association (SAPA) hosted a career forum with young professionals at Rutgers University. This forum is co-organized by the Rutgers University iJOBS program, Rutgers Chinese Students and Scholars Association, Association of Chinese... - March 10, 2016 - Sino-American Pharmaceutical Professionals Association
Addressing the Challenges in Biomanufacturing
The life sciences industry is evolving on a global scale. Shifting market demands, health care reforms and more stringent regulations are presenting new challenges to the industry at large. Taking a holistic approach to the challenges and opportunities that biomanufacturers face, Generis' American Biomanufacaturing Summit 2016 will present attendees with first-hand case studies, strategies and best practices to advance manufacturing excellence, drive innovation and develop the necessary leaders. - March 10, 2016 - Generis Group
New Podcast “How Organizations are Navigating Risk Based Approaches in Clinical Trials” Now Available on WorldCongress.com
UCB Biosciences, Inc.’s Director/Head, Risk Based Monitoring, Justin, Stark, addresses centralized monitoring and on-site monitoring and how organizations are navigating risk based approaches in a new podcast available on the World Congress website. The podcast is geared toward those involved in clinical trial design, operations and risk management. - March 09, 2016 - World Congress
Makers Nutrition Launches Premium Stock Formulas
Fast-Growing Nutraceutical Company Offers Nine Popular Stock Formulas to Vitamin and Supplement Businesses - March 08, 2016 - Makers Nutrition, LLC
Versaic Launches Solution to Streamline Medical Affairs for Pharmaceuticals
New solution integrates easy to use interface, fully customizable process, time-saving reporting features, and ongoing support from dedicated client success managers. - March 03, 2016 - Versaic
Biobanking Conference to Tackle Regulatory Updates and Impacts on Industry
SMi Group reports (2016.29.02 – London, UK): Registration is now live for the 6th annual Biobanking Conference and Exhibition on 20-21 June at the Holiday Inn Kensington Forum, London, UK. - March 02, 2016 - SAE Media Group
Ixogel®: Agreement on Special Protocol Assessment (SPA) by the US Food and Drug Administration for the Prevention of Lyme Disease
Ixodes AG, a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention of Lyme Disease, today announced that the company has reached agreement with the US Food and Drug Administration (FDA) on the phase III protocol according to the Special Protocol... - March 01, 2016 - Ixodes AG
AgmaSet for Nerve Health Launched in the Philippines
Gilad&Gilad, the exclusive manufacturer and supplier of AgmaSet®, a unique supplements for nerve health, is collaborating with JCS Pharmaceuticals Inc. for distribution in the Philippines According to Dr. Gad M. Gilad, CEO of Gilad&Gilad, "The Philippines Ministry of Health has... - March 01, 2016 - Gilad&Gilad
Recursion Pharmaceuticals Supports White House Precision Medicine Initiative
Recursion Pharmaceuticals today announced that it is part of a group of nationally recognized private and public institutions making commitments as part of President Obama's Precision Medicine Initiative to rapidly find new treatments for ultra-rare genetic diseases. - February 25, 2016 - Recursion Pharmaceuticals
Makers Nutrition Hires Stephen Finnegan as General Manager
Rapidly growing nutraceutical company turns to seasoned executive to help lead expansion. - February 25, 2016 - Makers Nutrition, LLC
Roche, GSK, Merck Serono, Sanofi-Aventis and Many More Will Meet in June at 11th Annual ADMET Conference and Exhibition
SMi Group reports: Big Pharma will meet at SMi’s 11th annual ADMET conference and exhibition which will take place on the 13th and 14th June 2016 in London, UK. - February 25, 2016 - SAE Media Group
Wego Health to Demonstrate the Importance of Patient Influencers During ePharma Summit 2016
Company will ask for a single question to show how the pharmaceutical industry can benefit from engaging patient community leaders. - February 24, 2016 - Wego Health
Agenda Now Released for the 5th Annual ADC Summit in London
SMI Reports: Agenda for the 5th annual ADC Summit presents a lineup of expert speakers from the ADC industry elite. - February 19, 2016 - SAE Media Group
Clarify Regulatory Uncertainties with the MHRA and US FDA at SMi’s 13th Annual Controlled Release Conference
SMi's 13th annual Controlled Release conference, taking place on 18-19 April 2016 in London, will feature case studies and project updates from leading regulatory bodies and global pharmaceutical companies. - February 19, 2016 - SAE Media Group
Agenda Released for Immunogenicity 2016: Accelerating Commercialisation of Your Next Gen Biotherapeutics
SMi Group reports: (17.02.2016, London): The agenda has now been released for SMi’s 3rd annual Immunogenicity conference which will take place on the 13th and 14th June 2016 in London, UK. - February 19, 2016 - SAE Media Group
Key Questions on Compliance with New Regulations for Medical Devices and In Vitro Diagnostic Products Addressed This April
SMi Training's CPD accredited masterclass: “Compliance with the New Regulations for Medical Devices and In Vitro Diagnostic Products” will take place on the 4th April in London, UK. - February 19, 2016 - SAE Media Group
MHRA, BARDA, European Commission and Big Pharma Gather Next Month at 18th Annual Superbugs & Superdrugs Summit: Attendee List Released
SMi Group have released a preliminary list of confirmed attendees for the 18th annual conference on Superbugs & Superdrugs taking place on 16th and 17th March 2016. - February 17, 2016 - SAE Media Group
Tabula Rasa Healthcare Pharmacy Simulation Software Tested by Schools of Pharmacy
Medication treatment is the most common medical intervention. Its imprecise use contributes to an estimated 45-50 million adverse drug events annually. Tabula Rasa's suite of software solutions provide prescribers, pharmacists and healthcare organizations with sophisticated and innovative tools to better manage the medication-related needs of patients. NiaRx provides electronic health record training and patient-case simulation for pharmacy students, the future of tomorrow's caregiving team. - February 15, 2016 - Tabula Rasa HealthCare
SMi’s Premier Pre-Filled Syringes Event Series to Launch in the West Coast
SMi Group proudly presents the inaugural Pre-Filled Syringes Conference, taking place in Mission Bay, San Diego, USA on June 6th -7th 2016. - February 14, 2016 - SAE Media Group
NuvOx Pharma receives FDA Orphan Drug Designation for Oxygen Therapeutic for Vaso-occlusive Crisis and Acute Chest Syndrome in Sickle Cell Disease
Tucson based pharmaceutical company NuvOx Pharma announced today that it has secured orphan drug designation from the FDA for its investigational drug NVX-508 for vaso-occlusive crisis (VOC) and acute chest syndrome (ACS) in sickle cell disease. VOC is one of the most severe complications of... - February 14, 2016 - NuvOx Therapeutics
Exclusive Interviews with the MHRA and the US FDA Released Ahead of Controlled Release 2016
SMi's 13th annual Controlled Release conference, taking place on 18th - 19th April 2016 in London, will feature an array of case studies and project updates from major global pharmaceutical companies and leading regulatory bodies. - February 14, 2016 - SAE Media Group
NuvOx Pharma Announces FDA Acceptance of IND to Initiate Clinical Trial for Vaso-Occlusive Crisis in Sickle Cell Disease
The FDA has notified NuvOx Pharma that it may proceed with a clinical trial for its Investigational New Drug (IND), NVX-508 for vaso-occlusive crisis (VOC) and acute chest syndrome (ACS) in sickle cell disease. VOC is one of the most severe complications of sickle cell disease and it typically... - February 13, 2016 - NuvOx Therapeutics
Real Endpoints’ RxScorecard™ Predicted Launch Failure of Major New Anti-Cholesterol Drugs
Analysis from 2015 showed that because PCSK9 inhibitors had not proved more than incremental value for most patients, payers would dramatically restrict their usage. Poor Q4 sales show that’s exactly what happened. - February 12, 2016 - Real Endpoints
Clinical Progress in Pancreatic Cancer Therapy Unveiled Next Week in London
Silenseed present exclusive clinical evidence on the effectiveness of siRNA against mutated KRAS in pancreatic cancer at RNA Therapeutics 2016 - February 11, 2016 - SAE Media Group
Agenda Released for ADMET 2016: Linking ADME and PK with Safety to an Overall Assessment of Risk and Benefit
SMi Group reports: (09.02.2016, London): The agenda has now been released for SMi’s 11th annual ADMET conference and exhibition which will take place on the 13th and 14th June 2016 in London, UK. - February 11, 2016 - SAE Media Group
Survey Reveals that Serialization Investments to Meet DSCSA Mandates are Expected to Deliver Business Value beyond Compliance
Improved returns and recall management are imperative goals cited by 42% of respondents. - February 09, 2016 - Acsis Inc.
Webinar to Explore "Serialization Lessons from the Front Lines of Distribution"
Acsis, AmerisourceBergen and Excellis discuss how serialization investments to meet DSCSA mandates can – and should – deliver business value beyond compliance. - February 06, 2016 - Acsis Inc.
Leading Expert from Medimmune to Chair 5th ADC Summit in London
SMI Group Reports (04.02.2016 – London, UK) Now in its fifth year and following the success of previous events, SMi's ADC Summit takes place in London on 23-24 May 2016. - February 06, 2016 - SAE Media Group
Coalition Forms to Study Medication Risk in Workforce Populations
Tabula Rasa HealthCare and The Greater Philadelphia Business Coalition on Health have partnered to examine the extent of medication risk in a diverse workforce population and the opportunities to mitigate that risk for the benefit of improving the health and welfare of employees and reducing unnecessary health care costs. - February 01, 2016 - Tabula Rasa HealthCare
Leading Pharmaceutical Companies to Speak at the 5th ADC Summit in London
Returning for its 5th year and following on from the major success of previous events, SMi’s ADC Summit brings together leading pharmaceutical companies to discuss ADC developments in London, UK on 23 – 24 May 2016. - January 30, 2016 - SAE Media Group
MHRA and US FDA Confirmed to Speak at Controlled Release 2016
SMi's 13th annual Controlled Release conference, taking place on 18th - 19th April 2016 in London, will feature case studies from an array of global pharmaceutical companies including GSK, Ipsen, Novo Nordisk, MedImmune, AstraZeneca, Lundbeck, Merck, UCB Pharma, Diurnal and more. - January 30, 2016 - SAE Media Group
The Practicalities of Targeted Cell Delivery: Senior Scientists Gather in London to Explore the Latest in RNA Therapeutics
SMi will open its doors to host RNA Therapeutics 2016 in just a few weeks’ time on 15th and 16th February in Central London. - January 30, 2016 - SAE Media Group
Pushing Collaboration and Financial Incentives in the Global Fight Against Superbugs
Incentives to push antibiotic drug development to be the focus of SMi's 18th annual Superbugs & Superdrugs summit. - January 30, 2016 - SAE Media Group
New Speakers Confirmed from Allergan, Genentech, Endo Pharmaceuticals and Parexel at SMi's 2nd Annual Lyophilization USA Conference
Due to four new speakers being added onto the agenda, SMi Group are delighted to announce that a new brochure has been released for the 2nd annual Lyophilization USA conference taking place on April 27th and 28th in Iselin, New Jersey. Those who have recently confirmed to present include Allergan, Genentech, Endo Pharmaceuticals and Parexel. - January 30, 2016 - SAE Media Group
Pharma Gets Ready for a Unified Patent Court and Unitary Patent Laws
SMi Training are delighted to introduce its forthcoming workshop taking place on 6th April in Central London: “Getting Read for the UPC and the Unitary Patent – The Do’s and Don’ts in Pharma.” - January 26, 2016 - SAE Media Group
SMi's ADC Summit 2016 to Highlight the Developments for Next Wave of Antibody-Drug Conjugates
SMi Group reports (2016.21.01): Registration now live for the 5th annual ADC Summit taking place at the Holiday Inn Kensington Forum, London, UK on the 23rd – 24th May 2016. - January 24, 2016 - SAE Media Group
Registration Now Open for the 10th Annual Clinical Trial Logistics Conference and Exhibition
SMi Group reports (2016.01.20 – London, UK): Registration is now live for the 10th annual Clinical Trial Logistics Conference and Exhibition on 23-24 May at the Holiday Inn Kensington Forum, London, UK - January 23, 2016 - SAE Media Group
FDA Finally Speeds Up Approval for Ovarian Cancer Drugs
The headline “FDA Regulator, Widowed by Cancer, Helps Speed Drug Approval” has created quite a buzz across the world. The article, published in The New York Times earlier this year, said that the death of Dr Richard Pazdur’s wife, Mary, who battled ovarian cancer for three years,... - January 22, 2016 - Allied Market Research
IQ4I Research & Consultancy Published a New Report on “Drug Discovery Outsourcing (DDO) Global Market”: Estimated to be Worth $29.0 Billion in 2022
IQ4I Research & Consultancy published a new report on “Drug Discovery Outsourcing (DDO) Global Market – Forecast To 2022” which analyzes and studies the major competition, market drivers & Opportunities, Restraints & Threats in North America, Europe, Asia-Pacific and Rest of the World, spread through 182 slide. - January 14, 2016 - IQ4I Research & Consultancy Pvt. Ltd.
Drug Safety Company Expands Operations
Drug Safety Navigator, LLC (DSN) Announces Another Expansion in Its Fifth Year of Operation - January 13, 2016 - Drug Safety Navigator, LLC
Network with Leading Drug Delivery Experts from Around the World at SMi’s Pre-Filled Syringes 2016
SMi Reports: SMi’s 8th Annual Conference and Exhibition on Pre-Filled Syringes will take place in less than 2 weeks’ time on the 27th-28th January 2016 in London. - January 13, 2016 - SAE Media Group
Rx Partnership Receives $10,000 Critical Community Needs Grant from Dominion to Support Medication Access at Northern Neck Free Health Clinic
Grant will be used to provide the equivalent of $14.3M in prescription medications. - January 07, 2016 - Rx Partnership
Now More Hope for Menopausal Women Experiencing the Physical and Emotional Impact of Painful Sex and Vaginal Dryness
New clinical data released on Prasterone (DHEA) Vaginal Ovules' positive effect on moderate to severe dyspareunia (Painful sex due to menopause) and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause. - January 06, 2016 - Endoceutics
H2Biologics Licenses Worldwide, Exclusive Rights to Develop SD1-Granzyme B Drug Conjugate for Treatment of Mesothelin-Expressing Tumors
H2Biologics announced that it has been granted a worldwide, exclusive license by the Research Development Foundation (RDF) for the use of human granzyme B (GrB), a naturally occurring serine protease, in developing an immunoconjugate with a human single domain antibody (SD1) that targets... - December 31, 2015 - H2Biologics Inc.
Arlington Free Clinic Hosts Senator Adam Ebbin and Rx Partnership Board of Directors
State Senator Adam Ebbin (D-30th) and Rx Partnership’s Board of Directors toured the Arlington Free Clinic (AFC) on December 4 during the board’s quarterly meeting. Senator Ebbin and board members were able to learn about the clinic’s daily operations, challenges the clinic faces... - December 30, 2015 - Rx Partnership
National Benefit Builders, Inc. (NBBI) Reaches $750,000,000.00 in Confirmed Savings Through It's Americas Drug Card Program
National Benefit Builders has saved consumers $750,000,000 through it's discount prescription program. - December 21, 2015 - National Benefit Builders, Inc.